Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Falling Short(s)

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Dec 21, 2021 2:09pm

118 Views

Post# 34251436

RE:RE:RE:Falling Short(s)

"And what does the trial completion bring?

It will soon be a year. Why is the MATERIAL detalis of this PARTNERSHIP still hidden? Why are some in position trading on this info?" - hmmmmm

Bingo, bango, bongo !

Logic suggests that this would be promoted and Nas-da-queued if there was not more to the story.

<< Previous

Bullboard Posts

Next >>

Canada Nickel unveils second of seven resources planned by mid-2025